Skip to main content

Table 1.

Baseline Characteristics of Study Patients Who Were Ventilated Mechanically on Day 1 According to Renal Replacement Therapy Intensity Randomized Groups

Characteristic Less-Intensive Strategya More-Intensive Strategyb P Valuec
Age, mean ± SD, y 59.3 ± 15.3 59.3 ± 15.3 .95
Male, % 68.5 72.3 .21
Black, % 15.5 16.4 .71
Mean weight, mean ± SD, kg 84.2 ± 19 83.6 ± 19.5 .67
Patients alive at 14 days, n/No. (%) 288/451 (63.8) 293/456 (64.2) .75
Hypertension, % 2.6 2.8 .20
Diabetes mellitus, % 24.6 30 .14
Malignancy, % 13.5 18.4 .11
Ischemic heart disease, % 21.3 21.7 .73
Congestive heart failure, % 21 20.6 .80
Primary treating service, n/No. (%) .65
 Medical 198/451 (43.9) 214/456 (46.9)
 Surgical 201/451 (44.5) 191/456 (41.8)
 Other 52/451 (11.5) 51/456 (11.1)
Mode of renal replacement therapy on day 1, n/No. (%) .14
 Continuous venovenous hemodiafiltration 314/388 (80.9) 313/395 (79.2)
 Intermittent hemodialysis 53/388 (13.6) 61/395 (15.4)
 Sustained low efficiency dialysis 15/388 (3.9) 20/395 (5.0)
 Isolated ultrafiltration 6/388 (1.5) 1/395 (0.2)
Chronic hypoxemia, % 9 10.9 .39
Cardiovascular Sequential Organ Failure Assessment score (range) 3 (0 to 4) 3 (0 to 4) 1
Apache II score, mean ± SD 27.5 ± 7.1 28.1 ± 6.7 .2
Serum calcium, mean ± SD, (mg/dL) 7.5 ± 1.1 7.5 ± 1 .71
Serum creatinine, mean ± SD, mg/dL 3.6 ± 1.5 3.6 ± 1.5 .72
Serum phosphate, mean ± SD, mg/dL 5.4 ± 2.2 5.4 ± 2.1 1
Serum albumin, mean ± SD, g/dL 2.3 ± 0.3 2.3 ± 0.4 1
a

No. of participants with events = 154/451.

b

No. of participants with events = 113/456.

c

P value for difference; significant testing was done by χ2 for categoric variables and by t- test for continuous variables.